VANCOUVER, British Columbia (Jan. 3, 2024) — HydroGraph Clean Power Inc. (CSE: HG) (OTCQB: HGCPF) (the “Company” or “HydroGraph”), a commercial manufacturer of high-quality nanomaterials, announced today that its flagship
HydroGraph Clean Power Inc. announced that its graphene product, FGA-1, has been successfully trialed in Hawkeye Bio’s biomedical sensor aimed at the early detection of lung cancer. Read more.
HydroGraph Clean Power Inc., a commercial manufacturer of nanomaterials, announced that its flagship graphene product, FGA-1, has been successfully trialed in Hawkeye Bio’s biomedical sensor aimed at the early detection
The HydroGraph Blog reveals how next-generation graphene is reshaping plastics, composites, coatings, concrete, lubricants, energy storage, and biosensors. If you’re pushing for lighter, stronger, more efficient materials, it cuts straight to the breakthroughs – and trade-offs – driving the next wave of engineering innovation.
